Studies have shown that patients with type 2 diabetes exhibit increased concentrations of C-reactive protein (CRP) and interleukin-6 (IL-6), both of which are associated with a higher risk of diabetes-related complications (5). This evidence concerns the gene IL6 and type 2 diabetes mellitus.